PP-32 Palliative care in the context of rare diseases and the valuable integration of genetic data

<h3></h3> Currently over 7,000 rare diseases with a low prevalence and mainly affecting children are known. Of these, about 80% show a complex genetic landscape, 95% do not have adequate resolutive treatment, and 30% of affected children die before the age of 5 years old. Considering the life-threatening scenarios that often significantly reduce patients’ survival, the aim of this presentation is to analyze the current end-of-life approaches and to suggest an early characterization of the recurrence risk in patients’ relatives by integrating genetic data. An extensive literature review was conducted on PubMed with ‘palliative care in rare diseases’ and ‘palliative care in genetic diseases’ keywords and only relevant research and guidelines articles were selected in the 2010–2024 publication date range. The literature shows that, although oncological palliative care is the most established model, the clinical pictures of patients living with a genetic rare disease often require similar levels of physical, mental and network support. However, considering the progressively debilitating and often uncertain course of genetic rare diseases, a ‘transitional’ end-of-life care model should be implemented, offering the opportunity to gradually approach invasive medical interventions and to emotionally process the eventuality of patient’s Do Not Resuscitate orders or death. Genetic counselling, integrated with the patient’s and their relatives’ genetic analysis, might help to relieve parents’ feelings of distress and guilt, to provide more prognostic details, and to estimate or recognize early family recurrence risk, highlighting potential genetic inheritance patterns. The literature review shows that end-of-life care needs to be tailored based on the single patient and their disease to significantly improve quality of life, avoid dysthanasia and support the patient and their family in accepting a possible fatal outcome and managing bereavement.

Authors

Institutions

Publication Details

Published
2025-02-01
DOI
https://doi.org/10.1136/spcare-2025-mcrc.49
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PP-32 Palliative care in the context of rare diseases and the valuable integration of genetic data

Alfio V. Parisi, Rosaura Parisi
Genomics and Rare Diseases
article

PP-32 Palliative care in the context of rare diseases and the valuable integration of genetic data

Alfio V. Parisi, Rosaura Parisi
article en

Abstract

<h3></h3> Currently over 7,000 rare diseases with a low prevalence and mainly affecting children are known. Of these, about 80% show a complex genetic landscape, 95% do not have adequate resolutive treatment, and 30% of affected children die before the age of 5 years old. Considering the life-threatening scenarios that often significantly reduce patients’ survival, the aim of this presentation is to analyze the current end-of-life approaches and to suggest an early characterization of the recurrence risk in patients’ relatives by integrating genetic data. An extensive literature review was conducted on PubMed with ‘palliative care in rare diseases’ and ‘palliative care in genetic diseases’ keywords and only relevant research and guidelines articles were selected in the 2010–2024 publication date range. The literature shows that, although oncological palliative care is the most established model, the clinical pictures of patients living with a genetic rare disease often require similar levels of physical, mental and network support. However, considering the progressively debilitating and often uncertain course of genetic rare diseases, a ‘transitional’ end-of-life care model should be implemented, offering the opportunity to gradually approach invasive medical interventions and to emotionally process the eventuality of patient’s Do Not Resuscitate orders or death. Genetic counselling, integrated with the patient’s and their relatives’ genetic analysis, might help to relieve parents’ feelings of distress and guilt, to provide more prognostic details, and to estimate or recognize early family recurrence risk, highlighting potential genetic inheritance patterns. The literature review shows that end-of-life care needs to be tailored based on the single patient and their disease to significantly improve quality of life, avoid dysthanasia and support the patient and their family in accepting a possible fatal outcome and managing bereavement.

University of Salerno (IT)
Openalex Percentile: Top 97%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.